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ABSTRACT Pulmonary surfactant, a lipid/protein complex that lines the air/water interface in the mammalian lung, functions to
reduce the work of breathing. Surfactant protein B (SP-B) is a small, hydrophobic protein that is an essential component of this
mixture. Structure-function relationships of SP-B are currently under investigation as the protein and its peptide analogs are
being incorporated into surfactant replacement therapies. Knowledge of the structure of SP-B and its related peptides in bulk and
monolayer phases will facilitate the design of later generation therapeutic agents. Prior infrared reﬂection-absorption
spectroscopic studies reported notable, reversible surface pressure-induced antiparallel b-sheet formation in a synthetic
peptide derived from human SP-B, residues 9–36 (SP-B9–36). In the current work, infrared reﬂection-absorption spectroscopy is
applied in conjunction with isotopic labeling to detect the site and pressure dependence of the conformational change. SP-B9–36,
synthesized with 13C¼O-labeled Ala residues in positions 26, 28, 30, and 32, shifted the b-sheet marker band to ;1600 cm1
and thus immediately identiﬁed this structural element within the labeled region. Surface pressure-induced alterations in the
relative intensities of Amide I band constituents are interpreted using a semiempirical transition dipole coupling model. In
addition, electron micrographs reveal the formation of tubular myelin structures from in vitro preparations using SP-B9–36
in place of porcine SP-B indicating that the peptide has the potential to mimic this property of the native protein.
INTRODUCTION
Pulmonary surfactant is a lipid/protein mixture which is
suggested to reduce the work of breathing in mammalian
lungs by forming a ﬁlm that modiﬁes the surface properties
of the air/alveolar interface. The chemical composition of
surfactant is well established. Approximately 90% of the
mass is lipid, of which the majority (80–90%) is phospho-
lipid. The most abundant single component is 1,2-dipalmi-
toylphosphatidylcholine (DPPC) which constitutes;40% of
the mass. Anionic lipids such as phosphatidylglycerol (PG)
constitute ;10–15% of the lipid mass (Johansson and
Curstedt, 1997).
Four surfactant speciﬁc proteins (SP-A, SP-B, SP-C, and
SP-D) have been identiﬁed. Of these, SP-B and SP-C are
relatively small, hydrophobic molecules which modify the
properties of the surface ﬁlms. Both proteins enhance the rate
of phospholipid adsorption and spreading from the subphase
to the air/water interface (Pe´rez-Gil and Keough, 1998).
These observations have led to the design of therapeutic
agents for respiratory distress syndrome, a pathological con-
dition resulting from surfactant deﬁciency. In premature
infants, treatments for this disease include natural bovine or
porcine extracts, and synthetic preparations of lipid mixtures
alone or in combination with isolated SP-B and/or SP-C
(Robertson and Halliday, 1998; Johansson et al., 2001).
These therapeutic interventions have had mixed success
clinically.
The critical nature of SP-B is evident from observations
that inherited deﬁciency of SP-B and SP-B/mice develop
lethal respiratory disease (Nogee et al., 1994; Clark et al.,
1995; Tokieda et al., 1997). Alveolar type II cells in SP-B
knockout mice lack well-formed lamellar bodies, which
suggests that SP-B plays a role in the generation of this
surfactant storage structure (Clark et al., 1995). Functional
consequences of this also arise as lamellar bodies are re-
leased into the alveolar hypophase, where these densely
packed structures are transformed into tubular myelin (TM).
TM, the direct precursor of the surface active ﬁlm, requires
both SP-B and hydrophilic, oligomeric SP-A for its in vivo
and in vitro formation (Hawgood et al., 1998).
The potential for using SP-B and its peptide analogs for
therapeutic intervention has resulted in a plethora of studies
geared toward elucidating structure-function relationships
for this protein. The mature lipid-associated peptide is
79 amino acids in length, containing ;50% hydrophobic
residues with a net charge of 17 (Weaver and Conkright,
2001; Hawgood et al., 1998). The human sequence is shown
in Fig. 1 A. Although the three dimensional structure for the
protein has not been reported, sequence homology places SP-
B in the saposin-like family for which the NMR structure for
NK-lysin has been reported (Liepinsh et al., 1997). Six of the
seven cysteine residues in SP-B are highly conserved,
forming intramolecular sulfhydryl bridges. A generally
accepted structure for the SP-B monomer consists of four
to ﬁve amphipathic helical segments with a total helical
content of ;50% (Patthy, 1991; Andersson et al., 1995;
Weaver and Conkright, 2001).The remaining nonhomolo-
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gous cysteine residue, Cys48, forms an intermolecular
disulﬁde bond generating a homodimer which is the pre-
dominant form of the isolated protein.
An inherent property of SP-B is its strong association with
lipids, setting this protein apart from other saposin-like
members which are only transiently lipid-associated. In the
bulk phase, SP-B binds to liposomes, causing destabilization
and lipid mixing (Hawgood et al., 1998). These attributes are
consistent with the suggested role of SP-B in the packaging
of surfactant in lamellar bodies and in the delivery to and
dynamics of surfactant at the air/water interface. The protein
is thought to interact with lipid headgroups, particularly the
anionic phosphatidylglycerol species with the dimer possibly
bridging two bilayers or from bilayer to monolayer. While
studies have shown that SP-B enhances adsorption and
spreading of surfactant phospholipids at air/liquid interfaces,
tends to promote respreading of a compressed ﬁlm, and
modulates ﬁlm composition during dynamic compression
and expansion, the molecular mechanisms underlying these
actions are poorly understood.
Peptide analogs of SP-B have been employed to better
understand the molecular mechanisms of action and to
facilitate the design of formulations for therapeutic in-
tervention. This synthetic mimetic approach has been
undertaken using two strategies. First, SP-B domains have
been modeled with synthetic peptides possessing regions
of the native primary sequence producing some useful
structural insights. For example, a peptide containing the ﬁrst
25 residues presumed to consist of the ﬁrst amphipathic
helical segment, SP-B1–25, has been shown to increase the
collapse pressure of palmitic acid monolayers (Longo et al.,
1993) and induce reversible folding upon collapse and
subsequent expansion of surfactant monolayers (Ding et al.,
2001). This behavior paralleled that of the full length, native
SP-B sequence, and is most likely attributed to an ionic
interaction between the net positive charge carried by both
the protein and peptide and the anionic nature of the fatty
acid monolayer. In addition, SP-B1–25 and its Cys8 S-S-
linked homodimer enhanced surface ﬁlm formation and
dynamics with the dimer improving lipid respreadability
(Veldhuizen et al., 2000). A second design strategy initiated
by Cochrane and colleagues attempts to examine the effects
of SP-B’s hydrophobic-hydrophilic pattern and charge
distribution on surface activity. Analysis of the C-terminal
region of SP-B led to the synthesis of peptides such as
(KL4)4K (Cochrane and Revak, 1991; Johansson et al.,
2001).
The evaluation of structure-function relationships in
Langmuir ﬁlms that model surfactant is limited by the
paucity of techniques available for the direct in situ
determination of protein structure in aqueous monolayers.
Thus, current routine evaluation of synthetic peptide
conformation involves structural (for example, nuclear
magnetic resonance, circular dichroic, and infrared) meas-
urements in various bulk phase environments coupled with
surface activity measurements in monolayers. However,
secondary structure determined in bulk phase environments
may differ from that found in monolayers, invalidating the
correlations drawn between bulk phase structure and surface
activity (Dieudonne´ et al., 1998). It is evident that secondary
structure determination of surfactant proteins and related
peptides in monolayers is essential for understanding their in
vivo function.
In the mid-1980s, Dluhy and co-workers demonstrated the
feasibility of acquiring IR reﬂection-absorption (IRRAS)
spectra from aqueous Langmuir ﬁlms of fatty acids and
phospholipids in situ at the air/water interface (Dluhy and
Cornell, 1985; Dluhy, 1986). With the success of these
measurements, IRRAS provided the means to determine
aspects of molecular structure and interactions between
monolayer ﬁlm constituents. A variety of biologically-
motivated extensions of this technology ensued. Of those
related to pulmonary surfactant, this laboratory used IRRAS
to evaluate the conformation of porcine SP-B in the presence
and absence of lipids in Langmuir ﬁlms where the protein
FIGURE 1 (A) Sequence of human SP-B and (B) the SP-B9–36 peptide
with 13C¼O labeled Ala residues denoted with (*). (C) Secondary structure
predictions and hydrophobicity index for human SP-B calculated using
PredictProgram (see text for references). The propensities for the 9–36
peptide are highlighted within the dashed line region.
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was observed to maintain its predominantly a-helical
structure (Pastrana-Rios et al., 1995).
IRRAS has also been used to evaluate lung surfactant-
related peptides (Bi et al., 2002; Dieudonne´ et al., 2001). In
one prior study, upon which the current investigation is
based, this laboratory examined the secondary structure of
the synthetic SP-B fragment consisting of native residues
9–36, SP-B9–36 (Dieudonne´ et al., 2001). A reversible
surface pressure-induced conformational change from
a-helix $ antiparallel b-sheet structure was observed. The
current study advances investigation of this peptide in two
directions. First, prior IRRAS measurements are extended
through the use of 13C isotope labeling to pinpoint the
location within the sequence of the surface pressure-induced
conformational change in the peptide, SP-B9–36. To our
knowledge, this represents the ﬁrst reported use of peptide
isotopic labeling in conjunction with IRRAS measurements.
Conﬁdence in the interpretation of spectral changes is
strengthened through use of a theoretical model developed to
explain anomalous intensities in the solution IR spectra of
13C-labeled peptides in the b-sheet conformation (Brauner
et al., 2000). Finally, a possible functional role for this
fragment is suggested through the electron microscopy-
based observation of tubular myelin formation in bulk phases
where native SP-B has been replaced with SP-B9–36.
MATERIALS AND METHODS
Materials
The reagents and solvents used for peptide synthesis were obtained from
PerSeptive Biosystems (Framingham, MA). HPLC-grade solvents and salts
(Aldrich, Milwaukee, WI and Fisher Scientiﬁc, Pittsburgh, PA) were used
for the puriﬁcation of peptides, isolation of surfactant proteins, and
preparation of samples. Trizma hydrochloride, HEPES, EDTA, DPPC,
egg PG, and sodium chloride were obtained from Sigma (St. Louis, MO).
Deuterium oxide (D2O, 99.9%) was purchased from Cambridge Isotope
Laboratory (Andover, MA). TAAB 812 resin and sodium cacodylate were
purchased from Marivac (Halifax, NS).
Peptide design and synthesis
The primary sequence of the SP-B peptide used in the current experiments
(*SP-B9–36) including the position of the isotopically labeled Ala residues
(A*) is shown in Fig. 1 B. This region of the native sequence, i.e., residues
9–36, was chosen because it encompasses two predicted helical segments
(see Fig. 1 C). Secondary structure predictions in the human sequence were
conducted using PredictProgram (Rost and Sander, 1993a,b, 1994).
Positioning of the 13C¼O labeled residues was based on both the predicted
increase in b-sheet propensity in the C-terminus of the peptide (Fig. 1 C) and
the enhanced Amide I band intensity distribution observed for alternating
13C¼O/12C¼O residues in an antiparallel b-sheet structure (Brauner et al.,
2000). Replacing one Cys residue (Cys11) in the human sequence with Ala
was found to reduce disulﬁde bond formation to an undetectable level as
indicated by mass spectrometry (see following).
Peptide synthesis and puriﬁcation followed the same protocol as
described in Dieudonne´ et al. (2001). Brieﬂy, the peptide was synthesized
using standard procedures for solid phase Fmoc chemistry on a Millipore
9050 Plus synthesizer and was cleaved from the PAC-PEG-PS solid support
to obtain a C-terminal carboxylic acid. *SP-B9–36 was puriﬁed by reverse-
phase HPLC using a YMC ODS-AL semipreparative column (Waters,
Milford, MA) with an eluent gradient of water/acetonitrile, both containing
0.1% TFA. The identity and purity of the fraction collected was conﬁrmed
by electrospray ionization mass spectrometry. Mass spectrometry analysis
was performed at various ionization energies to evaluate dimerization due to
disulﬁde bond formation. Mass spectra at all ionization energies showed
only one major component having a molecular weight consistent with
monomer *SP-B9–36.
Bulk phase Fourier transform infrared
spectroscopy
Fourier transform infrared transmission spectra were collected for the *SP-
B9–36 in methanol (;2 mg/mL) at ambient temperature. A ﬁxed pathlength
(100 mm) CaF2 sample cell was used. Spectra were obtained using a Mattson
RS-1 (Madison, WI) spectrometer with a mercury-cadmium-telluride
detector. Interferograms were collected with a total of 1024 scans acquired
at ;4 cm1 spectral resolution in eight blocks of 128 scans each, co-added,
apodized with a triangular function, and Fourier-transformed with one level
of zero ﬁlling to yield spectra encoded at 2 cm1 intervals. Analysis of the
Amide I region was made after subtraction of a pure methanol spectrum from
the sample.
Monolayer sample preparation, IRRAS
measurements, and spectral analysis
Pure *SP-B9–36 peptide was dissolved in chloroform/methanol (4:1, v/v) at
;0.5 mg/mL and native SP-B was prepared in chloroform/methanol (1:1,
v/v) at ;1 mg/mL.
A D2O-based subphase consisting of 100 mM NaCl and 0.1 mM EDTA
in 10 mM Tris buffer at pD 7 was used for all IRRAS experiments. A D2O
buffer is used to eliminate the reﬂectance-absorbance from the H2O bending
vibration and to lessen the absorbance from the rotation-vibration bands of
water vapor, both of which occur in the conformation-sensitive Amide I
spectral region. A custom-designed Langmuir trough (maximum surface
area of 86 cm2) constructed by Nima Technology (Coventry, England),
equipped with a Model PS4 surface pressure sensor, was used for all
experiments. The subphase temperature was held at 21.0 6 0.58C. Aliquots
of 20–25 mL and 10 mL were spread dropwise on a clean surface for *SP-
B9–36 and native SP-B, respectively. A minimum 45-min period was allowed
for solvent evaporation and ﬁlm relaxation/equilibration before compres-
sion. All samples were spread with initial pressure \4 mN/m and p-A
isotherms were acquired during intermittent compression and expansion. A
relaxation period of ;20 min was allowed between stopping the barrier at
desired surface pressure values and IRRAS spectral acquisition. The surface
pressure drop during the relaxation period was small,\3 mN/m in the high
pressure region and\1 mN/m in the low pressure region.
IRRAS spectra were acquired with a Equinox 55 Spectrometer (Bruker
Optics, Billerica, MA) equipped with an external variable angle reﬂectance
accessory, the XA-511. The accessory has been coupled to the Langmuir
trough. A detailed description of the instrument has been published (Flach
et al., 2001). Brieﬂy, the infrared (IR) beam is directed through the external
port in the spectrometer and is reﬂected by three mirrors in a rigid mount
before being focused on the water surface. Computer-driven stepper motors
rotate the mirrors to obtain the desired angle of incidence. A wire grid
polarizer is placed into the optical path directly before the beam impinges on
the water surface. The reﬂected light is collected at the same angle as the
angle of incidence, follows an equivalent mirror path, and is directed onto
a narrow band mercury-cadmium-telluride detector. The entire experimental
setup is enclosed and purged to keep the relative humidity levels as low and
as constant as feasible.
Interferograms were collected with the use of a sample shuttle program
to compensate for the residual water vapor rotation-vibration bands in the
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Amide I region. A total of 1024 scans were acquired at 8 cm1 resolution, in
two blocks of 512 scans each, co-added, apodized with a Blackman-Harris-
3-term function, and fast Fourier-transformed with two levels of zero-ﬁlling
to produce spectral data encoded at 2 cm1 intervals. Spectra were acquired
using s-polarized radiation at a 358 angle of incidence and p-polarized
radiation at 408. Polarized radiation can be used in IRRAS measurements
to obtain the orientation of transition dipoles and therefore, tilt angles of
particular molecular segments of interest. This topic has been recently
elaborated upon in a review by Mendelsohn and Flach (2002), and an article
of Bi et al. (2002). IRRAS band intensities measured for spectra obtained
using p-polarized radiation are much more sensitive to changes in transition
dipole orientation than their s-polarized counterparts. Therefore, spectra
acquired using s-polarized radiation generally provide information about
molecular structure or conformation as obtained from the band positions
(frequencies), whereas the band intensities generated using p-polarization in
conjunction with s-polarization provide orientation information.
Data analysis was performed using Grams/32 (Galactic Industries, Salem,
NH). Spectra are presented after linear baseline correction. Water vapor
subtraction was not necessary. IRRAS spectra of the Amide I region were
curve-ﬁt, using two Gaussian bands and limiting the width at half-height for
the band found at ;1597 cm1 to 25 6 5 cm1.
Transition dipole coupling model and
spectral simulations
A semiempirical method has been developed to quantitatively examine the
complex Amide I contour in the IR spectra of proteins and peptides (Brauner
et al., 2000). The method, which calculates Amide I band components for
a-helical and antiparallel b-sheet geometries, is based on transition dipole
coupling and interactions through valance bonds between adjacent
oscillators and through hydrogen bonds. Simulations reproduced the
downward frequency shift observed for a single 13C¼O substituent in an
a-helical peptide. This frequency shift can also be predicted using
elementary methods based on the increased mass in an harmonic oscillator
approximation. The utility of the semiempirical method was demonstrated
by simulations of several 13C¼O-labeled b-sheet peptides where an
anomalous intensity distribution in Amide I band components (not predicted
by elementary methods) was reproduced. In the current study, the majority
of the parameters required as input were taken directly from the work of
Brauner et al. (2000). A few were modiﬁed to obtain a better ﬁt to the
experimental IRRAS spectra and are listed here. An initial, unperturbed
frequency of 1665 cm1 was used for both b-sheet and a-helical geometries.
Amide I band constituents for both conformations were generated by
representing each component as a 30/70 Gaussian/Lorentzian function with
a half-width of 12 cm1 for the b-sheet component band and 18 cm1 for the
a-helical modes. The effect of hydrogen-deuterium exchange on Amide I
band positions can be accommodated for in the simulations by adjusting the
H-bonding interaction constant and/or the initial, unperturbed frequency,
although the calculation does not explicitly require the mass of hydrogen or
deuterium.
Surfactant protein isolation and tubular
myelin preparation
SP-B was isolated from porcine lavage by the method of Curstedt et al.
(1988) and Taneva and Keough (1994). SP-A from porcine lavage was
prepared by the method of Haagsman et al. (1987) and Taneva et al. (1995).
The concentration of protein was determined by ﬂuorescamine assay
(Udenfriend et al., 1972), and amino acid analysis (Sarin et al., 1990) was
performed. Lipid concentration was determined by phosphorus assay
(Bartlett, 1959; Keough and Kariel, 1987).
DPPC/egg PG (7:3 molar ratio) and 15% (by weight) SP-B or SP-B9–36
were mixed in 1:1 chloroform/methanol, dried under N2, and evacuated
overnight in a vacuum desiccator. Two mL of buffer (10 mM Tris, 145 mM
NaCl, and 1 mM EDTA, pH 7.4) was added to the dried sample, which was
then hydrated at 468C for 1 h, with frequent vortexing. The sample was
centrifuged at 50,000 g for 30 min, the pellet resuspended in 150 ml buffer,
and the lipid content determined. SP-A in buffer (5 mM HEPES, pH 7.4)
was added, to give a ﬁnal SP-A concentration of 22% of the phospholipid
weight. After a 10–15 min incubation at 378C, calcium was added to a ﬁnal
concentration of 5 mM. The sample was incubated overnight at 378C with
continuous mixing.
For the isolation of native tubular myelin, rat lungs were lavaged twice
with 0.9% NaCl and 5 mM calcium. The lavage was centrifuged at 48C for
10 min at 150 g to remove cell debris and the supernatant centrifuged at
40,000 g for 15 min. The pellets were resuspended in 500 ml of the
remaining supernatant.
Electron microscopy
Gluteraldehyde and osmium tetroxide (OsO4) in a sodium cacodylate buffer
were added to the lipid/protein samples to give a ﬁnal concentration of 2%
glutaraldehyde, 1% OsO4, and 0.1 M sodium cacodylate (pH 7.4). After 1 h
at room temperature, the sample was pelleted in a microfuge and left
overnight. The sample was again centrifuged, supernatant was removed and
replaced with 2% uranyl acetate. The sample was held at 48C overnight. The
pellet was then dehydrated using acetone, from 70–100% in 10% steps,
before being embedded in TAAB 812 resin. After cutting, the sections were
stained with uranyl acetate and lead citrate and viewed using a Zeiss EM 109
electron microscope (Carl Zeiss Canada, Toronto, Canada).
RESULTS
Bulk phase IR spectra of the Amide I region for the unlabeled
SP-B9–36 peptide and the
13C-carbonyl group-labeled de-
rivative (*SP-B9–36) acquired inmethanol are shown in Fig. 2.
Two major Amide I band components are observed for the
unlabeled peptide at ;1657 and 1628 cm1 which indicate
the presence of a-helical and antiparallel b-sheet structures,
respectively. The weak high frequency component of the
antiparallel b-sheet structure usually observed at ;1690
cm1 is obscured by the dominant a-helical band at 1657
cm1. Isotopic labeling of the peptide changes the Amide
I band proﬁle markedly as a new band is observed at
FIGURE 2 Bulk phase IR spectra of the Amide I and II region for the
labeled and unlabeled SP-B9–36 peptides in methanol at ;2 mg/mL.
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1600 cm1. Assignment of the low frequency band to antipar-
allel b-sheet structure in the 13C-labeled region of the peptide
is consistent with an anticipated downward isotopic shift.
The observed frequency decrease of ;28 cm1 is less than
that expected for 13C substitution in an isolated C¼O stretch-
ing frequency (;37 cm1) due to the presence of alternating
labeled and unlabeled oscillators. This observation will be
elaborated on in the Discussion. Some intensity is also
observed in the 1620–1630 cm1 region in the spectrum of
the *SP-B9–36 peptide suggesting that a small amount of
b-sheet structure may be present in the unlabeled region
of this peptide or that additional secondary structure ele-
ments are present in the labeled region of the peptide.
IRRAS experiments were conducted on monolayers of
*SP-B9–36 and compared to native porcine SP-B and the
unlabeled SP-B9–36 under similar conditions. Fig. 3 displays
IRRAS spectra of all three acquired at a surface pressure of
;27 mN/m. A large Amide I band constituent assigned to
antiparallel b-sheet structure is observed for both the labeled
(1597 cm1) and the unlabeled (1626 cm1) peptides,
whereas the native protein shows much less intensity in the
1626 cm1 region at the air/water interface. The predominant
Amide I component for the three monolayers is found at
;1645 cm1, most likely indicative of a-helical or a mix of
helix/random coil structures after H!D exchange. The
extent of exchange is essentially complete as revealed by the
absence of an Amide II band at ;1550 cm1.
In a previous publication, unlabeled SP-B9–36 was shown
to exhibit reversible surface pressure-induced antiparallel
b-sheet formation in both the presence and absence of a lipid
monolayer (Dieudonne´ et al., 2001). With the potential to
extract the additional structural information provided by
speciﬁc isotopic labeling, similar IRRAS experiments were
conducted using *SP-B9–36. IRRAS spectra of the Amide I
region for a *SP-B9–36 peptide monolayer are displayed
in Fig. 4 A. The spectra were acquired using s-polarized
radiation during the compression and subsequent expansion
of the monolayer. The relative intensity of the low frequency
FIGURE 3 IRRAS spectra (1750–1540 cm1 region) of native, porcine
SP-B, and the labeled and unlabeled SP-B9–36 peptide monolayers acquired
using s-polarization at surface pressure of ;27 mN/m on a D2O-buffered
subphase.
FIGURE 4 IRRAS spectra of the Amide I region acquired for *SP-B9–36
on a D2O subphase. (A) Spectra are acquired using s-polarization and surface
pressure values are noted from top to bottom during compression and
subsequent expansion of the monolayer. The inset displays the pressure
dependence of the relative area of the curve ﬁt 1597 and 1640 cm1 Amide I
band components during intermittent compression (d) and expansion () of
the ﬁlm. (B) Spectra acquired using p-polarized radiation during the
compression of an *SP-B9–36 peptide monolayer.
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component (1597 cm1) is observed to increase upon
compression and decrease as the surface area is expanded.
This observation is more clearly displayed in the inset to the
ﬁgure, where the ratio of the curve ﬁt band areas (1597/1645
cm1) are plotted as a function of surface pressure. Although
there is some scatter in the data, the trend and its reversibility
are apparent. In addition, a substantial difference in the
widths of the two major Amide I band components is evident
in Fig. 4 A. This most likely reﬂects heterogeneity in the
mixture of helix/random coil structures for the 1645 cm1
constituent and a more homogeneous b-sheet structure for
the 1597 cm1 component.
To evaluate whether the observed Amide I intensity
variations arise from changes in the orientation of secondary
structure elements within the peptide, IRRAS spectra were
also acquired using p-polarized radiation (shown in Fig. 4 B).
Although the noise level in the spectra acquired using
p-polarization is slightly greater than in the s-polarized
spectra, the relative intensity changes observed upon com-
pression are essentially the same for both polarizations when
comparing spectra at similar surface pressure values. This
observation demonstrates that the majority of the intensity
variation in theAmide I contour is not due to pressure-induced
alterations in orientation as has been previously detailed in Bi
et al. (2002). Possible structural factors responsible for this
phenomenon are referred to the Discussion.
Electron micrographs of tubular myelin (TM) structures
isolated from rat lavage and prepared from native, porcine
SP-B, and SP-B9–36 are shown in Fig. 5 A–C, respectively.
Surface balance experiments have shown that the presence of
meshlike TM structures isolated from surfactant fractions
appear to enhance adsorption and spreading when compared
to surfactant fractions rich in small vesicles (Goerke, 1998).
Although less TM is observed in the micrographs prepared
using the 9–36 peptide compared to native SP-B (;1% vs.
10% of micrograph area counted, respectively), the gener-
ation of even small amounts of TM with the peptide suggests
that certain properties of the peptide are sufﬁcient to mimic
the native protein’s role in TM formation.
DISCUSSION
With the thought of potential therapeutic agents in mind,
many surfactant-based peptides are currently under evalua-
tion. It is important to evaluate these peptides in both bilayer
and monolayer environments. Understanding the mechanics
of peptide function in lung-related environments will likely
aid in the elucidation of intact pulmonary surfactant protein
function as well. In the current investigation, IRRAS, in
conjunction with isotopic labeling, has been applied to
determine the location of particular secondary structure
elements within an SP-B-based peptide that is also shown to
form the physiologically relevant structure of tubular myelin.
The bulk phase spectra (Fig. 2) immediately identify the
position of b-sheet secondary structure within the peptide to
the general region of the 13C¼O label. The reversible
formation of an antiparallel b-sheet structure is evident for
SP-B9–36, both from the current spectra and from our earlier
investigations.
Several structural issues arising from the current experi-
ments bear comment. The formation of an antiparallel (in
contrast to parallel) b-sheet is not surprising, considering
that residues 9–20 (the N-terminal of SP-B9–36) exhibit
a substantial propensity toward helix formation (see Fig. 1).
Indeed, the most intense IRRAS spectral feature (Fig. 3) is
assigned to an overlapped contour arising from helix/random
secondary structure that is not much altered by isotopic
labeling. Thus, the formation of the intermolecular antipar-
FIGURE 5 Electron micrographs of (A) tubular myelin isolated from rat
lungs, bar¼ 500 nm; (B) an in vitro preparation of TM using native, porcine
SP-B, bar ¼ 500 nm; and (C) TM prepared in vitro using SP-B9–36 in place
of native SP-B, bar ¼ 250 nm.
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allel b-sheet structure, which is localized to residues beyond
residue;20 or so, can be rationalized on the basis that steric
hindrance induced by the presence of helical/random
structures at the N-termini of two strands in close proximity
will limit the ability of intermolecular parallel sheets to form.
To understand the spectra in more detail, we have
developed a model for simulating Amide I contours using
a semiempirical approach which incorporates transition
dipole coupling and through-bond interactions within the
context of the Wilson FG matrix method (Wilson et al.,
1955). This approach produced excellent agreement between
calculated and observed Amide I spectra for four isotopic
variants (13C in selected residues) of the K2(LA)6 peptide
(Brauner et al., 2000).
Fig. 6 A displays simulated spectra of the Amide I region
for an antiparallel b-sheet peptide consisting of two strands
with 12 amino acid residues each. The dependence of peak
position on the placement of 13C¼O labels is evident. The
frequencies of the simulated major Amide I components are
observed at 1626, 1599, and 1585 cm1 for the unlabeled,
alternating labeled/unlabeled, and fully labeled peptides,
respectively. The position of the low frequency Amide I
component for the unlabeled peptide and peptide with
alternating labels are essentially the same as those observed
experimentally for the corresponding unlabeled and labeled
SP-B9–36 peptides, indicating that the assignment of b-sheet
structure to the labeled region of the peptide is indeed
correct. It is interesting to note that the full magnitude of the
predicted 37 cm1 frequency shift (based on the harmonic
oscillator model of a simple diatomic molecule) is re-
produced in the simulated spectrum of the fully labeled
antiparallel b-sheet peptide. Simulations also reveal that the
attenuation in the magnitude of the frequency shift for the
alternating labels is due to coupling between 13C¼O and
12C¼O oscillators.
An interesting consideration in the current work is the
nature of the aggregation state (dimers or more extended
structures) of these peptides on the aqueous surface. Casual
inspection of the Amide I contour cannot reveal the
aggregation state as the IR spectra-structure correlations
commonly used were established for secondary structure.
Determination of higher order structural elements along with
elucidation of the effects of isotopic substitution on the
Amide I contour require a theoretical approach for spectral
simulation. The implicit assumption made in the semi-
empirical simulations in Fig. 6 is that dimers were the
aggregation state, although the nature of the model is such
that simulations of higher order aggregates would prob-
ably also lead to agreement between the observed and cal-
culated Amide I contour. More recently, Keiderling and his
colleagues (Kubelka and Keiderling, 2001) have carried out
elaborate (ab initio) calculations to simulate the Amide I
contour in isotopically labeled antiparallel b-sheets of
various aggregation states of the K2(LA)6 peptides. They
conclude that the characteristic intensity enhancement of
FIGURE 6 Calculated IR spectra of the Amide I region using a transition
dipole coupling method as described by Brauner et al. (2000). (A)
Simulations of three peptides, 12 residues in each strand, arranged in an
antiparallel b-sheet geometry: (—) all unlabeled residues, (– –) alternating
13C¼O/12C¼O, and (–  –) all 13C¼O labeled residues. (B) Experimental
spectrum of *SP-B9–36 acquired at a pressure of 4 mN/m overlaid with an
inverted simulated spectrum of two identical peptides with their C-termini in
an antiparallel b-sheet geometry. Each peptide consists of 14 residues in an
a-helical geometry coupled to an antiparallel b-sheet strand containing
seven residues with 13C¼O labels as noted (d) in inset. (C) Experimental
spectrum acquired at a pressure of 29 mN/m and simulated spectrum similar
to B, except that the b-strand portion of each peptide consists of 11 residues,
with the labeling differing as noted in the inset. The b-sheet components in
the simulated spectra in B and C were multiplied by 1.5 before being added
to the helical component.
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some components of the contour (observed experimentally
in this laboratory) requires sheets comprised of clusters of
least ﬁve strands to obtain agreement between experimental
and simulated results.
To utilize either the ab initio or semiempirical models to
explain the IRRAS observations of surface pressure-induced
intensity enhancement of the 1600 cm1 band requires
consideration of the following experimental facts, as well as
limitations of the theoretical approaches:
1. The surface pressure-dependent helix/random$ b-struc-
ture interconversion is reversible. It seems reasonable to
suggest that this experimental observation is incompat-
ible with extensive strand formation, which (in bulk
phases) would probably lead to gel formation and
concomitant irreversibility.
2. The forces that stabilize secondary structures at the air/
water interface are most likely quite different than in bulk
phases. Kubelka and Keiderling (2001) note that, for
K2(LA)6, ‘‘if the strands were to align in an exact
antiparallel fashion. . .the leucine side chains on neigh-
boring strands would point alternatively above and below
the b-sheet plane, thus causing no packing hindrance.’’
They indicate that multistrand formation could easily be
accommodated within this model. While these statements
are certainly reasonable, they may not be applicable to
the SP-B9–36 peptide. In the current instance, steric
effects imposed by the presence of helix/random con-
formations at the N-terminal may hinder the inter-
action between the individual strands and limit the
formation of multistrands.
3. Both the ab initio calculations and the semiempirical
approach assume an idealized geometry for each b-strand.
This may be a severe approximation for simulations of the
current IRRAS data, as it is unlikely that the small peptide
strands interacting here, at the asymmetric environment of
the air/water interface, would assume an ideal structure.
The effects of structural variations from idealized
b-geometries on the results of either the ab initio or
semiempirical spectral simulations cannot be easily
predicted without extensive computations.
Thus, the nature of the experimental conditions (IRRAS,
presence of more than one secondary structure) and
limitations on the theoretical calculations (short segments,
unknown geometry) would seem to suggest that both
theoretical approaches require severe approximations. The
spectral simulations discussed below are presented with the
above limitations in mind.
To provide an initial explanation for the observed surface
pressure-induced changes in the Amide I contour, we utilized
the semiempirical model to analyze the relative increase in
the 1597 cm1 component in the Amide I region as a function
of surface pressure (see Fig. 4). It is important to apply
the model in a way that is consistent with the IRRAS
observations, e.g., reversible surface pressure-induced re-
sults for both the labeled and unlabeled peptides. The
previous report for the unlabeled peptide describes an
increase in the relative intensity of the b-sheet Amide I
band component versus the helical/unordered component
with surface pressure (Dieudonne´ et al., 2001) similar to
that observed in the current investigation. One possible
interpretation is represented in Fig. 6, B and C, where
simulated spectra that have been inverted are overlaid with
experimental IRRAS spectra at low (4 mN/m) and high (29
mN/m) surface pressure. The simplest model to account for
the observed spectral changes is an increase in the number of
peptide bonds in the b-sheet region with increasing pressure.
Simulations carried out with the number of peptide bonds in
the b-sheet region of both strands increasing from 14 with
ﬁve being isotopically labeled (at 4 mN/m) to 22 with eight
labels (29 mN/m) reproduced the changes monitored in the
experimental spectra. Schematic depictions of the b-sheet
region in each case are shown as insets in Fig. 6, B and C.
This simple model accounts for the pressure-dependent
changes observed in the unlabeled SP-B9–36 peptide as well.
We recognize that as our knowledge of the detailed three-
dimensional structure of the peptide at the air/water interface
increases, more sophisticated models will be applicable for
modeling the surface pressure-induced alterations.
A detailed mechanism of the above-described event
requires the formation and cleavage of hydrogen bonds as
surface area is reduced and subsequently expanded. Similar
reversible phenomena involving a lung surfactant SP-C-
based peptide were recently reported, although the compo-
sition of secondary structure differed in that peptide (Bi et al.,
2002). In the SP-C peptide system, the extent of helix
hydration varied with surface pressure. Although conditions
in both the SP-C and SP-B9–36 peptide monolayer experi-
ments differ substantially from the natural system, surface
pressure-induced conformational ﬂexibility in surfactant-
based peptides may be relevant to the functional properties of
pulmonary surfactant proteins at the air/alveolar interface.
Structural transitions in the peptide may also be important
in promoting the formation of tubular myelin. Furthermore,
electrostatic interactions between anionic lipids and native
SP-B are presumed to play a role. *SP-B9–36 carries the
majority of the positive charge (15) for the native protein (net
charge 17). It is possible that the concentration of positive
charge is an important factor in the initiation of TM formation.
A few synthetic peptides based onN-terminal regions of SP-B
have been successful in substituting for the native protein in
TM preparations. These include the SP-B1–25 monomer and
dimer peptides, along with SP-B11–25 (Keough et al., 2002),
all of which carry a15 charge. However, attempts to generate
tubular myelin with a derivative of the 11–25 peptide where
all the positively charged residues were replaced with Ser,
have not been successful (Keough et al., 2002). An earlier
publication on synthetic SP-B1–25 peptides containing amino
acid substitutions that altered charge and hydrophobicity
reported reduced surface activitywith reversal of charge in the
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peptide and a correlation between helical structure in bulk
phase and the degree of interaction with lipids (Bruni et al.,
1991). The pressure-dependent secondary structure of
SP-B1–25 and its related peptides has not yet been determined
at the air/water interface. In the current work, the importance
of electrostatic interaction appears clear, whereas establishing
a relationship between structure and lipid interaction in both
monolayers and TM needs further investigation.
The low abundance of TM in reconstituted systems in
conjunction with the required presence of SP-B and SP-A
make the investigation of protein structure in TM extremely
difﬁcult. The observation of TM in the in vitro preparations
with SP-B9–36 in place of the native protein along with
isotopic labeling to enhance the resolution of Amide I
constituents provides the ﬁrst step in overcoming these
difﬁculties.
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